| 11/12/2026 3:07 PM | Brackmann Christoph (2048634) Reporting NovoCure (1645113) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 3:07 PM | NovoCure (1645113) Issuer Paravasthu Mukund (2039078) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/09/2026 3:07 PM | Brackmann Christoph (2048634) Reporting NovoCure (1645113) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/09/2026 5:59 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/29/2026 5:59 AM | NovoCure (1645113) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/29/2026 6:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/29/2026 6:01 AM | NovoCure (1645113) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 10/01/2026 8:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/09/2026 6:02 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/01/2026 6:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/01/2026 3:30 PM | Leonard Frank X (1822879) Reporting NovoCure (1645113) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NVCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/01/2026 3:33 PM | NovoCure (1645113) Issuer Puri Michal Nath (1997032) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 6:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 6:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/04/2026 4:41 PM | Leonard Frank X (1822879) Reporting NovoCure (1645113) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/08/2026 4:01 PM | NovoCure (1645113) Subject Soleus Capital Master Fund, L.P. (1812275) Filed by | Form SCHEDULE 13G/A | |
| 04/30/2026 6:01 AM | NovoCure (1645113) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/30/2026 6:01 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 2:29 PM | NovoCure (1645113) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/20/2026 3:05 PM | NovoCure (1645113) Filer | Form DEF 14A | |
| 04/20/2026 3:06 PM | NovoCure (1645113) Filer | Form DEFA14A | |
| 04/09/2026 4:04 PM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/26/2026 10:52 AM | NovoCure (1645113) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/26/2026 6:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 4:54 PM | Brackmann Christoph (2048634) Reporting NovoCure (1645113) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 4:42 PM | NovoCure (1645113) Subject Paravasthu Mukund (2039078) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 4:53 PM | NovoCure (1645113) Subject Weinberg Uri (1811030) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 3:09 PM | Ben Arye Barak (1917165) Reporting NovoCure (1645113) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 3:09 PM | Leonard Frank X (1822879) Reporting NovoCure (1645113) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 4:40 PM | Leonard Frank X (1822879) Reporting NovoCure (1645113) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/27/2026 4:13 PM | Leonard Frank X (1822879) Reporting NovoCure (1645113) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/26/2026 6:01 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 6:01 AM | NovoCure (1645113) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/26/2026 6:05 AM | NovoCure (1645113) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/11/2026 4:24 PM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/05/2026 7:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 4:30 PM | NovoCure (1645113) Issuer Paravasthu Mukund (2039078) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:00 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 3:21 PM | Ben Arye Barak (1917165) Reporting NovoCure (1645113) Issuer | Form 5 Annual statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:21 PM | Danziger Asaf (1654435) Reporting NovoCure (1645113) Issuer | Form 5 Annual statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:22 PM | NovoCure (1645113) Issuer Puri Michal Nath (1997032) Reporting | Form 5 Annual statement of changes in beneficial ownership of securities | |
You missed yesterday's deadline… (Ad) In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years.
While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars. See which company controls this entire energy discovery now. |
| 12/01/2025 6:01 AM | NovoCure (1645113) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |